• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical and economic burden of heparin-induced thrombocytopenia in hospitalized patients undergoing percutaneous peripheral arterial interventions.

作者信息

Subahi Ahmed, Osman Mohammed, Adegbala Oluwole, Abubakar Hossam, Kheiri Babikir, Yassin Ahmed S, Khalid Mowyad, Akintoye Emmanuel, Eljack Ammar, Osman Khansa, Alkhouli Mohamad

机构信息

Department of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, MI, USA.

Department of Cardiology, West Virginia University School of Medicine, Morgantown, WV, USA.

出版信息

Vascular. 2020 Feb;28(1):81-86. doi: 10.1177/1708538119868615. Epub 2019 Aug 5.

DOI:10.1177/1708538119868615
PMID:31382836
Abstract
摘要

相似文献

1
Clinical and economic burden of heparin-induced thrombocytopenia in hospitalized patients undergoing percutaneous peripheral arterial interventions.接受经皮外周动脉介入治疗的住院患者中肝素诱导的血小板减少症的临床和经济负担
Vascular. 2020 Feb;28(1):81-86. doi: 10.1177/1708538119868615. Epub 2019 Aug 5.
2
Heparin-induced thrombocytopenia: an estimate of the average cost in the hospital setting in France.肝素诱导的血小板减少症：法国医院环境下的平均成本估计。
Clin Appl Thromb Hemost. 2009 Jul-Aug;15(4):428-34. doi: 10.1177/1076029608319441. Epub 2008 Jun 10.
3
Differences in risk factors and resource utilization for women undergoing percutaneous coronary intervention and lower extremity peripheral vascular intervention.行经皮冠状动脉介入治疗和下肢外周血管介入治疗的女性患者的危险因素和资源利用的差异。
Catheter Cardiovasc Interv. 2020 Jul;96(1):136-142. doi: 10.1002/ccd.28431. Epub 2019 Aug 9.
4
Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes.肝素诱导的血小板减少症（HIT）：临床和经济结果。
Thromb Haemost. 2008 Dec;100(6):1130-5.
5
Clinical and economic evaluation of ambulatory endovascular treatment of peripheral arterial occlusive lesions.外周动脉闭塞性病变门诊血管内治疗的临床与经济学评估
Ann Vasc Surg. 2014 Jan;28(1):137-43. doi: 10.1016/j.avsg.2013.06.008. Epub 2013 Oct 30.
6
[Heparin-induced thrombocytopenia type II (HIT II) : A medical-economic view].[II型肝素诱导的血小板减少症（HIT II）：医学经济学视角]
Med Klin Intensivmed Notfmed. 2017 May;112(4):334-346. doi: 10.1007/s00063-016-0237-x. Epub 2016 Dec 22.
7
Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients.达肝素与未分级肝素预防危重症患者静脉血栓栓塞的成本效益比较。
JAMA. 2014 Nov 26;312(20):2135-45. doi: 10.1001/jama.2014.15101.
8
Comparison of the Cost of Drug-Eluting Stents versus Bare Metal Stents in the Treatment of Critical Limb Ischemia in the United States.美国药物洗脱支架与裸金属支架治疗严重肢体缺血的成本比较
Ann Vasc Surg. 2019 Feb;55:55-62.e2. doi: 10.1016/j.avsg.2018.05.051. Epub 2018 Aug 6.
9
Bivalirudin versus heparin in patients undergoing percutaneous peripheral interventions: A systematic review and meta-analysis.比伐芦定与肝素用于接受经皮外周介入治疗患者的疗效比较：一项系统评价和荟萃分析。
Vascular. 2019 Feb;27(1):78-89. doi: 10.1177/1708538118807522. Epub 2018 Dec 1.
10
The direct medical costs associated with suspected heparin-induced thrombocytopenia.疑似肝素诱导的血小板减少症相关的直接医疗费用。
Pharmacoeconomics. 2011 Jun;29(6):511-20. doi: 10.2165/11584330-000000000-00000.

引用本文的文献

1
Heparin Induced Thrombocytopenia for the Perioperative and Critical Care Clinician.围手术期及重症监护临床医生的肝素诱导性血小板减少症
Curr Anesthesiol Rep. 2020;10(4):501-511. doi: 10.1007/s40140-020-00405-6. Epub 2020 Aug 29.